Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (RTRX), sold 7,500 shares at $23.98 ($180K) on 2020-11-16, disclosed to the SEC on 2020-11-17.
Open-market sale of $180k RTRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |